William Slayton, MD - Research

Research at a glance

Top areas of exploration

Hematopoietic Stem Cells , 12 publications
Bone Marrow Transplantation , 10 publications
Bone Marrow Cells , 9 publications
Hematopoietic Stem Cell Transplantation , 8 publications

Research activity

86 publications

2,301 citations

Why is this important?

Active clinical trials

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Ne

Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: N/A - 21 Years
Sexes: All

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mix

This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. This trial also studies the outcomes of patients with mixed鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: 1 Year - 25 Years
Sexes: All

Bleomycin, Carboplatin, Etoposide, or Cisplatin in Pediatric and Adult Patients With Germ Cell Tumor

This partially randomized phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor鈥�

Investigators: Brian Stover, William Slayton
Status: Accepting Candidates
Ages: N/A - N/A
Sexes: All

My publications

86 publications

2012

Characteristics of thawed autologous umbilical cord blood.

Transfusion

鈥�

2012

Continuous Dose Dasatinib Is Safe and Feasible in Combination With Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ All): Children's Oncology Group (Cog) Trial Aall0622

Blood

2012

Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.

Oncology (Williston Park, N.Y.)

2012

Juvenile myelomonocytic leukemia in a 16-year-old with Noonan syndrome: case report.

Journal of pediatric hematology/oncology

2012

Outstanding Early Responses With Dasatinib and Intensive Chemotherapy in Pediatric Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph Plus All): Children's Oncology Group (Cog) Trial Aall0622

Pediatric Blood & Cancer

网红黑料